[Date Prev][Date Next][Thread Prev][Thread Next][Date Index][Thread Index]
RE: Merck published fake journal
- To: <liblicense-l@lists.yale.edu>
- Subject: RE: Merck published fake journal
- From: "Kosecki, Stan" <Stan.Kosecki@ARS.USDA.GOV>
- Date: Mon, 11 May 2009 20:32:55 EDT
- Reply-to: liblicense-l@lists.yale.edu
- Sender: owner-liblicense-l@lists.yale.edu
David, According to May 7, 2009 statement by Michael Hansen, CEO Of Elsevier's Health Sciences Division, http://www.elsevier.com/wps/find/authored_newsitem.cws_home/companynews05_01203 " [...] We are currently conducting an internal review but believe this was an isolated practice from a past period in time." --Stan Kosecki -----Original Message----- From: owner-liblicense-l@lists.yale.edu [mailto:owner-liblicense-l@lists.yale.edu] On Behalf Of David Prosser Sent: Friday, May 08, 2009 5:47 PM To: liblicense-l@lists.yale.edu Subject: RE: Merck published fake journal Irony lovers will enjoy going back to 2004 and re-reading the evidence Crispin Davis, former CEO of Reed Elsevier, gave to the UK House of Commons Committee on Science and Technology. Right in the middle of this interesting practice Sir Crispin was commenting on the quality and objectivity safeguards of the subscription models - safeguards that would be undermined by open access. He also mentioned that 25% of Elsevier revenue came form the commercial sector, including Merck. We now know how that came about. [SNIP]
- Prev by Date: Re: Merck published fake journal
- Next by Date: Re: Merck published fake journal
- Previous by thread: Re: Merck published fake journal
- Next by thread: Re: Merck published fake journal
- Index(es):